Companies: 10,795·Total market cap: $144.5T
Novacyt S.A.

Novacyt S.A.

NVYTFOTCHealthcare● Active
$0.48
$-0.00(-0.00%)
Market Cap$34772652
P/E Ratio
52W High$0.641
52W Low$0.48
Overview

Novacyt S.A.(NVYTF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NVYTF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.68nvytf eps ttm · nvytf earnings per shareEarnings history
PE Ratio (TTM)nvytf pe ratio ttm · nvytf price to earningsPE Ratio deep dive
Revenue (TTM)$29.3Mnvytf revenue ttm · nvytf annual revenueFull revenue history
Dividend Yield不分红does nvytf pay dividends · nvytf dividend yieldDividend history
Shares Outstanding70.6Mnvytf shares outstanding · nvytf floatShares outstanding history
Next EarningsSep 24, 2026Est.nvytf earnings date · nvytf next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$20.4M▲ +3.86% YoY
202320242025
novacyt s.a. revenue · nvytf revenue 2025
FY 2025Net Income-$23.3M▲ +44.22% YoY
202320242025
novacyt s.a. net income · nvytf profit 2025
FY 2025EPS$-0.33▲ +44.07% YoY
202320242025
nvytf eps · novacyt s.a. earnings per share 2025
TTM:Revenue: $29.3MNet Income: -$46.7MEPS: $-0.68View income statement →

股票表现

完整历史
1D-0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD-5.88%
1Y-10.78%
5Y-89.94%

关于 Novacyt S.A.

CEOLyn Dafydd Rees
IPO DateJan 8, 2021
Employees234
CountryFR

Novacyt S.A. along with its subsidiaries, specializes in the global development, manufacturing, bespoke design, and commercialization of diagnostic products. These offerings are instrumental in ident…

what is novacyt s.a. · nvytf stock overview · novacyt s.a. company profile · who is novacyt s.a. ceo · nvytf OTC · novacyt s.a. headquarters · novacyt s.a. business segments

关于股票概览与关键数据

Novacyt S.A.(NVYTF)是 Medical - Devices 行业的 Healthcare 类公司,于 Jan 8, 2021 在 OTC 上市。截至最近交易日,NVYTF 股价为 $0.48,市值约为 $34.8M。过去12个月累计回报 -10.78%,年初至今回报 -5.88%。

2025 财年 Novacyt S.A. 营收 $20.4M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Novacyt S.A.(NVYTF)股价为 $0.48,在 OTC 上市,52周区间为 $0.48 – $0.64。

NVYTF 最新股价NVYTF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议